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The Ami-AliA/AliB oligopeptide permease of Streptococcus pneumoniae has been
suggested to play a role in environmental sensing and colonisation of the nasopharynx
by this human bacterial pathogen by binding peptides derived from bacterial neighbours
of other species in the microbiota. Here, we investigated the effects of the peptide
ligands of the permease’s substrate binding proteins AmiA, AliA, and AliB on
pneumococcal phenotype. AmiA and AliA ligands reduced pneumococcal growth,
increased biofilm production and reduced capsule size. In contrast, AliB ligand increased
growth and greatly increased bacterial chain length. A decrease in transformation rate
was observed in response to all three peptides. Changes in protein expression were
also observed, particularly those associated with metabolism and cell wall synthesis.
Understanding interspecies bacterial communication and its effect on development of
colonising versus invasive phenotypes has the potential to reveal new targets to tackle
and prevent pneumococcal infections.
Keywords: Streptococcus pneumoniae, interspecies communications, growth, biofilm, capsule, chaining, ABC
transporters
INTRODUCTION
Streptococcus pneumoniae (pneumococcus) is one of the most extensively studied microorganisms,
but this opportunistic pathogen remains a major causative agent of several human diseases
including otitis media, pneumonia, sepsis and bacterial meningitis. However, the pneumococcus
is more often a harmless inhabitant of the human nasopharynx, a niche it shares with many other
microorganisms. Sensing of these microbial neighbours has been proposed to occur by binding of
short peptides of these other bacterial species by S. pneumoniae via oligopeptide binding proteins
of ATP-binding cassette (ABC) transporters (Hathaway et al., 2014). ABC transporters are also of
interest as virulence factors since mutations in some have resulted in a reduction in pneumonia and
bacteraemia in mouse models (Polissi et al., 1998; Lau et al., 2001).
One ABC transporter, the Ami-AliA/AliB permease, has been suggested to play a role
in uptake of environmental signals and in competence for genetic transformation (Claverys
et al., 2000). One of these permease’s oligopeptide binding proteins, AliB, has also been
shown to aid in colonisation of the nasopharynx in a mouse model (Kerr et al., 2004).
Previously, it has been shown that peptides found in other bacterial species are recognised
by homologs of AliB: AliB-like ORF1 and ORF2 in non-encapsulated S. pneumoniae
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and that binding of the proteins to their peptide ligands affected
pneumococcal phenotype and gene expression (Hathaway et al.,
2014; Nasher et al., 2018a).
For the three substrate binding proteins of the Ami-
AliA/AliB permease, we have shown recently that AmiA binds
peptide AKTIKITQTR, matching an amino acid sequence
found in 50S ribosomal subunit protein L30; AliA binds
peptide FNEMQPIVDRQ, matching an amino acid sequence
found in 30S ribosomal protein S20 and AliB binds peptide
AIQSEKARKHN, matching an amino acid sequence found in
30S ribosomal protein S20 (Nasher et al., 2018b). These Ami-
AliA/AliB peptide ligands are found in multiple bacterial species
in the class of Gammaproteobacteria which includes common
colonisers of the nostrils and nasopharynx (Pettigrew et al., 2012;
Biesbroek et al., 2014; Mika et al., 2015; Teo et al., 2015). We
therefore speculate that the pneumococcus binds these peptides
to sense the presence and composition of its bacterial neighbours
and adapt by altering its phenotype.
We determined here the effects of binding of AmiA, AliA, and
AliB to their ligands on phenotypes associated with colonisation
or virulence in wild type strains and mutants lacking the substrate
binding proteins. Effects were found on growth, capsule size,
chaining, transformation rate, and biofilm as well as on the
pneumococcal proteome.
MATERIALS AND METHODS
Ethics Statement
The human nasopharyngeal epithelial cell line Detroit 562 (CCL-
138 was obtained from the American Type Culture Collection
(ATCC)).
Clinical isolates of S. pneumoniae were selected from two
nationwide surveillance programmes (Mühlemann et al., 2003;
Kronenberg et al., 2006), from anonymous donors and have been
used in previous studies (Hathaway et al., 2004, 2012).
Bacterial Culture and Strains
Strain D39 (serotype 2) pneumococci were used as the
parental strain for the production of mutants. Construction
of the individual, 1AmiA, 1AliA, 1AliB, and triple mutant
1AmiA/1AliA/1AliB was described previously (Alloing et al.,
1994; Kerr et al., 2004). Clinical isolates 106.66 (serotype 6B)
and 110.58 (non-encapsulated, classic lineage) (Hilty et al.,
2014) were also used. Bacteria, stored at -80◦C using Protect
bacterial preservers (Technical Service Consultants, Heywood,
United Kingdom), were grown on Columbia sheep blood agar
(CSBA) plates at 37◦C, 5% CO2. Overnight cultures were
prepared with 3–10 colonies in 5 mL brain heart infusion broth
(Becton Dickinson and Company, le Pont de Claix, France)
containing 5% foetal calf serum (FCS; Biochrom KG, Berlin,
Germany; BHI+FCS medium).
Growth Assay
Strains were streaked onto CSBA plates and incubated at 37◦C
in a 5% CO2-enriched atmosphere overnight then sub-cultured
in BHI+FCS medium to OD600nm 0.5, centrifuged at 3000 × g
for 5 min and resuspended in 5 mL chemically defined medium
(CDM) which contains 5.5 mM glucose (Schaffner et al., 2014).
Growth was monitored in sterile flat-bottomed 96-well microtiter
plates (Nunclon Surface, Nunc, Denmark) based on the method
of Brewster (2003). In brief, 200 µL bacteria culture was grown
per well at 37◦C and OD450nm measured every 30 min using a
VersaMax microplate reader (Molecular Devices) over 22 h with
or without peptide ligands (synthesised by PolyPeptide Group,
Strasbourg, France). The plate was shaken automatically for 5 s
before each reading. The problem of condensation affecting the
readings was avoided by pre-treating the lids of the 96-well plates
with 3 mL 0.05% Triton X-100 in 20% ethanol and allowing them
to air-dry before use (Hathaway et al., 2012).
Growth Competition Assay
D39 and its mutants 1AmiA, 1AliA, 1AliB, and
1AmiA/1AliA/1AliB were streaked onto CSBA plates and
incubated at 37◦C in a 5% CO2-enriched atmosphere overnight
then subcultured in BHI+FCS medium to OD600nm 0.5,
centrifuged at 3000 × g for 5 min and resuspended in 5 mL
CDM. 250 µL bacterial culture (125 µL of each of the two strains
being compared) was transferred to 4.75 mL CDM pre-warmed
to 37◦C. The initial inoculum was plated out to check that
there was a 1:1 mixture of the two bacterial strains. Peptide
ligands were added to a final concentration of 0.5 mg/mL, and
the culture incubated to an OD600nm 0.3. Serial dilutions in
PBS were plated onto CSBA plates with and without antibiotics
to differentiate between wild type (susceptible) and mutants
(resistant) strains. 1AmiA mutant was selected on 10 µg/mL of
tetracycline, 1AliB on 2 µg/mL of chloramphenicol, and both
1AliA and triple mutant 1AmiA/1AliA/1AliB on 1 µg/mL of
erythromycin/mL. After overnight incubation, the numbers of
colonies were counted and the colony forming units (CFU) for
each strain calculated.
FITC-Dextran Exclusion Assay
Capsule thickness was determined by measuring the zone of
exclusion of FITC-dextran as described previously (Gates et al.,
2004; Hathaway et al., 2012), using FITC-dextran of 2000 kDa
(Sigma-Aldrich) with the following difference, bacteria were
cultured overnight in BHI+FCS medium until OD600nm = 0.5
then 100 µL subcultured into 2 mL of CDM with and
without peptide ligands and grown to an OD600nm = 0.3. After
centrifuging at 3000 × g for 5 min the pellet was resuspended in
500 µL of PBS. 10 µL bacterial suspension was mixed with 2 µL
FITC-dextran (10 mg/mL in water), pipetted onto a microscope
slide and a coverslip applied firmly. The slides were viewed
using a Zeiss Axio Imager M1 fluorescence microscope with
a 100× objective and photographed by a Zeiss AxioCam HRc
camera. The images were converted to grayscale and analysed
with UTHSCSA ImageTool for Windows v3.0 (University of
Texas Health Science Center, San Antonio, TX, United States)
software. A bright field image was also photographed for each
fluorescent image recorded in order to count the number of
bacteria. Each image contained between 8 and 150 bacteria, five
images were counted per group in each of three independent
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experiments making a total of 15 images per group. Each data
point in Figure 3B represents one image.
Chain Formation
Bacteria were cultured overnight in BHI+FCS medium until
OD600nm = 0.5 then 100 µL sub-cultured into 2 mL of CDM with
and without peptide ligands and grown to an OD600nm = 0.3.
After centrifuging at 3000 × g for 5 min the pellet was
resuspended in 500 µL of PBS, 25 µL of the suspension was
put on microscope slides and Gram stained. The slides were
viewed using a Zeiss Axio microscope with a 100× objective
and photographed by a Zeiss AxioCam HRc camera. A bright
field image was acquired to count the number of bacteria per
chain. 5 to 78 bacterial chains were counted per image, five
images were counted per group in each of three independent
experiments making a total of 15 images per group. Each data
point in Figure 4B represents one image.
Adherence to Human Epithelial Cell Line
Adherence to the nasopharyngeal epithelial cell line Detroit
562 (CCL-138, from the ATCC) was performed as described
previously (Hathaway et al., 2004) with the following differences:
A total of 4 × 105 cells/well were cultured in a 24-well
tissue culture plate in Minimum Essential Medium+Earle’s
salts (MEM) containing 10% FCS, 2 mM L-glutamine, 1.5 g/L
sodium bicarbonate, 0.1 mM non-essential amino acids and
1 mM sodium pyruvate (Gibco, United Kingdom) until reaching
complete confluence at 37◦C in 5% CO2. S. pneumoniae strains
D39 and its mutants as well as strains 106.66 and 110.58 were
grown in BHI+FCS to the logarithmic phase OD600nm = 0.4 and
washed in MEM then resuspended to give 107 bacteria in 0.5 mL
MEM, which was added per well of washed Detroit cells. The
bacteria were centrifuged onto the cells at 390 × g for 5 min
at room temperature. After 1 h incubation of the cells with the
bacteria at 37◦C and five washes with PBS, 200 µL of trypsin was
then added to each well and incubated for 5 min in 37◦C to detach
the cells. Adhered bacteria were recovered, serially diluted in
0.85% NaCl and plated onto CSBA. CFU/mL was then calculated
after an overnight incubation at 37◦C in 5% CO2.
Biofilm Assay
Biofilm assays were performed as previously described (Marks
et al., 2012b) with the following modifications. A total of
4 × 105 Detroit cells/well in MEM salts containing 10% FCS,
2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 0.1 mM non-
essential amino acids and 1 mM sodium pyruvate (Gibco,
United Kingdom) were cultured in 24-well tissue culture plate
until reaching complete confluence at 37◦C in 5% CO2. Strains
D39 and its mutants and strains 106.66 and 110.58 were grown
in CDM to OD600nm 0.4 to give 105 bacteria in 0.5 mL per well.
5 µL salmon sperm DNA was added into each well and, where
indicated, corresponding peptide ligands, followed by 16 h of
static incubation at 37◦C, 5% CO2. The medium containing the
planktonic bacteria was removed and each well was washed twice
with PBS taking care not to disturb the biofilm. 200 µL PBS was
then added per well and the plate was sonicated for 6 s in a water
bath and then the biofilm scraped thoroughly from the wells. The
contents of the wells were recovered and the CFU determined
by plating out serial dilutions CSBA and incubating overnight at
37◦C.
Transformation Assay
To determine transformation rates of strain D39 and its
mutants, strains 106.66 and 110.58, bacteria were grown to
an OD600nm = 0.15 in BHI+FCS. A total of 0.5 mL of
the culture was transferred to 9.5 mL CDM prewarmed to
30◦C and incubated for 15 min at 30◦C in a waterbath.
Competence-stimulating peptide 1 (CSP 1; ERLSKFFRFILQRLL)
for D39 and its mutants and CSP 2 (EMRISRIILDFLFLRKK)
for 106.66 and 110.58 were added to final concentration
100 ng/mL with and without AmiA, AliA, and AliB peptide
ligands to a final concentration of 0.5 mg/mL, the culture
incubated for 15 min at 30◦C. Chromosomal DNA, 1 µg,
from streptomycin resistant strain 104.37 was added and the
culture incubated for 60 min at 30◦C, then 90 min at 37◦C.
Serial dilutions in PBS were plated onto CSBA plates with and
without 200 µg/mL streptomycin. After overnight incubation,
the numbers of colonies were counted and the transformation
rate calculated.
Proteomic Analysis
Strain D39 and its mutants were cultured overnight in BHI+FCS
medium until OD600nm = 0.5 then 100 µL sub-cultured into
10 mL of CDM and grown to an OD600nm = 0.2, the culture
was split into two 5 mL aliquots and 0.5 mg/mL of peptides
were added to one sample and incubated for 15 min at 37◦C.
Both cultures were centrifuged for 5 min at 4000 × g and
the pellets were resuspended in 50 mM Tris–HCl and 8 M
urea and sonicated. Sample processing, Liquid Chromatography
Mass Spectrometry (LC-MS/MS) and data interpretation was
essentially done as described previously (Engel et al., 2014) with
the following changes. LC-MS/MS analysis was carried out on
an UltiMate 3000 Nano LC coupled to an Orbitrap Fusion
Lumos instrument (Thermo Fisher Scientific) acquiring full MS
scans in the m/z range 400–1400 in the orbitrap at resolution
120,000 with AGC set to 4e5 and maximal ion injection time
of 50 ms. Peptide precursors with charge 2–8 were fragmented
once in the ion trap then excluded for 30 s. The ion trap settings
were data-dependent MS2 cycle time of 3 s, isolation width
of 1.6 m/z, fragmentation HCD mode with 30% normalised
collision energy, AGC of 1e4 with maximal ion injection time
of 35 ms. The LC-MS/MS data was processed with MaxQuant
(version 1.5.4.1) using default settings for peak detection, strict
trypsin cleavage rule allowing for up to three missed cleavages,
variable oxidation on methionine and acetylation of protein
N-termini with strict carbamidomethylation of cysteines. Match
between runs was activated with a retention time window
of 0.7 min. The fragment spectra were interpreted with the
S. pneumoniae strain D39 (serotype 2) ensemble database
(version gca_d39.ASM1436v1). LFQ intensities were used for
data analysis with imputation of missing values from the low
end of the LOG2 transformed intensity distribution of each LC-
MS/MS run using Perseus (version 1.5.5.3) as suggested by Lazar
et al. (2016).
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Statistics
For proteomics, differential protein expression analysis was
performed with t-tests within Perseus, including a permutation-
based false discovery rate estimation (cutoff at 5% and using
S0 function set at 0.5) to correct for multiple testing. For other
experiments two-way ANOVA or student t-tests were performed
to obtain p-values using the software GraphPad Prism (Version
7, GraphPad Software, Inc.).
RESULTS
Peptide Ligands Affect Pneumococcal
Growth
Streptococcus pneumoniae strain D39 (serotype 2) and its
mutants in which one or all three of the substrate-binding
proteins have been deleted (1AmiA, 1AliA, 1AliB, and
1AmiA/1AliA/1AliB) were grown in CDM in 96 well plates in
the absence and presence (at concentrations of between 0.5 and
0.062 mg/mL) of AmiA, AliA, and AliB peptide ligands for 22 h.
For strain D39, AmiA, and AliA peptide ligands reduced
growth significantly in a dose dependent way (Figures 1A,B)
whilst AliB peptide ligand slightly reduced the lag phase and
increased the maximum optical density (OD) (Figure 1C). To
check that these effects were peptide specific, D39 was grown
in the presence of peptides with single amino acid differences
from peptides AliA and AliB (Figure 1D). (FSEMQPIVDRQ
differs from AliA ligand at the second amino acid and
AIQSEKRRKHN differs from AliB ligand at the seventh amino
acid, underlined; a single amino acid version of AmiA peptide
was insoluble and so could not be used in the growth assay).
A single amino acid substitution caused AliA peptide to lose
its ability to suppress growth and the substitution in the AliB
peptide reduced its ability to boost growth response to the
peptide.
Less suppression of growth was seen by AmiA peptide in
the 1AmiA mutant supporting the idea that this is the specific
receptor for the peptide (Figure 1E). In contrast, AliA peptide
affects the 1AliA mutant in the same way as it affects the D39
wild type as expected since AliA peptide is known to bind to
AmiA receptor (Figure 1F; Nasher et al., 2018b). Unlike the
wild type D39 strain, growth of the D39 1AliB mutant was
reduced by the AliB peptide (Figure 1G). However, none of the
three peptide ligands had a great effect on the triple mutant
1AmiA/1AliA/1AliB indicating a redundancy of function
between the three substrate binding proteins (Figure 1H).
To test whether the peptides had the same effect on growth for
clinical isolates, we tested the effects on strain 106.66 (serotype
6B) and non-encapsulated strain 110.58 (Figures 1I,J). As for
D39, AmiA and AliA peptide ligands reduced growth whilst AliB
peptide ligand slightly shortened the lag phase for these clinical
isolates.
AmiA and AliA peptides have a bacteriostatic, rather than
bacteriolytic, effect as shown by plating out and counting CFU at
different timepoints during exponential growth (Supplementary
Figure S1).
Given the effects on growth by the peptides in Figure 1, next
we determined whether possession of the oligopeptide binding
proteins affected the outcome of a competition assay when wild
type strain D39 and each of its mutants were cultured together
in the presence of the peptides. Figure 2A shows that D39 is
outcompeted by both the mutant lacking AmiA (1AmiA) and
the triple mutant1AmiA/1AliA/1AliB when the AmiA peptide
is present but not when the AmiA peptide is absent (Figure 2B).
The same pattern is seen for AliA (Figure 2C) with mutants
lacking the receptor for the peptide having a growth advantage in
the competition assay when the peptide was present (Figure 2C)
but not when the peptide was absent (Figure 2D). In contrast, the
wild type D39 strain had a competitive advantage over the mutant
lacking AliB (1AliB) and over the triple mutant (Figure 2E).
D39 also had a growth advantage over the 1AliB mutant in the
absence of peptide, although to a lesser extent, and no advantage
over the triple mutant (Figure 2F).
(See Supplementary Figure S2 for all data points at
OD600nm = 0.1, 0.2, and 0.3).
The results of the competition assays support those of the
growth curves: peptides AmiA and AliA inhibit growth but AliB
enhances growth.
Peptides Affect Capsule Thickness
Since the polysaccharide capsule is a major virulence factor of
S. pneumoniae, we investigated whether any of the three peptides
affected capsule thickness. Figure 3A shows an example of a
FITC-dextran exclusion assay using strains D39 (serotype 2)
and 106.66 (serotype 6B). For both strains there was a clear
diminution of capsule size following incubation with AmiA
peptide. The results for all three peptides for both strains are
summarised in Figure 3B. The reduction in capsule thickness in
response to AmiA peptide was significant for both strains. AliA
peptide also reduced capsule thickness in both strains, although
the difference was only significant for strain D39. In contrast,
AliB peptide ligand caused a slight, non-significant, increase
in capsule thickness in strain D39 only (Figure 3B). None of
the three peptide ligands affected capsule thickness significantly
in the triple mutant 1AmiA/1AliA/1AliB (Supplementary
Figure S3). In the absence of peptide ligands, mutants had
thinner capsule than the parent strain D39. AliA peptide ligand
did not affect capsule thickness in the 1AliA mutant, nor did
AliB peptide ligand affect capsule thickness in the1AliB mutant.
AmiA peptide significantly increased capsule thickness in the
1AmiA mutant but only to a value equivalent to the capsule
thickness of D39 in the absence of peptide (Supplementary
Figure S3).
Peptide Ligands Affect Chain Length of
Encapsulated but Not Non-encapsulated
Pneumococci
When performing the capsule thickness experiments, we noticed
that the peptide ligands appeared to affect chain length of
the encapsulated pneumococci. We therefore quantified the
effects of the peptide ligands on chain length (Figure 4).
All three peptide ligands increased the average number of
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FIGURE 1 | Growth curves of pneumococcal strain D39, its mutants and strains 106.66 and 110.58 in the presence and absence of the peptide ligands of AmiA,
AliA, and AliB. Growth in chemically defined medium (CDM) was determined by measuring optical density over time for (A) wild type strain D39 in the absence
(control) and presence of AmiA peptide ligand (at the different concentrations indicated), (B) D39 in the absence and presence of AliA ligand, (C) D39 in the absence
and presence of AliB ligand, showing that AmiA and AliA ligands cause significant and dose dependent suppression of growth but AliB ligand does not. The effects
of peptides on growth were specific as shown in panel (D) where D39 was grown in the absence and presence (0.5 mg/mL) of peptides with a single amino acid
substitution: FSEMQPIVDRQ differs from AliA ligand at the second amino acid and AIQSEKRRKHN differs from AliB ligand at the seventh amino acid (underlined).
Growth curves in the presence of the unmodified ligands have been included to allow direct comparison. AmiA peptide had much less suppressive effect on growth
of the mutant lacking the AmiA receptor, D39 1AmiA (E). Whereas growth of the D39 1AliA mutant was suppressed by AliA peptide (F). Unlike the wild type D39
strain, growth of the D39 1AliB mutant was reduced by the AliB peptide (G). None of the three peptide ligands had a great effect on the triple mutant
1AmiA/1AliA/1AliB (H). Suppression of growth by AmiA and AliA peptides but not AliB peptide was also seen in two clinical pneumococcal isolates: strain 106.66
(serotype 6B) (I) and non-encapsulated strain 110.58 (J) (Peptide concentrations of 0.5 mg/mL). Curves show the mean values of at least three independent
experiments performed on different days, error bars equal SEM.
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FIGURE 2 | Competition assay between D39 and each of its mutants when cultured together in the absence and presence (0.5 mg/mL) of each of the peptides.
Strain D39 was cultured together with mutant 1AmiA or the triple mutant 1AmiA/1AliA/1AliB in panel (A) the presence or (B) absence of AmiA ligand, with mutant
1AliA or 1AmiA/1AliA/1AliB in panel (C) the presence or (D) absence of AliA ligand and with mutant 1AliB or the triple mutant 1AmiA/1AliA/1AliB in panel (E) the
presence or (F) absence of AliB ligand in CDM. When OD600nm reached 0.3, the bacteria were plated onto CSBA with and without antibiotics to differentiate
between the wild type and mutants and CFU counted. Results are as the mean ± SD of three independent experiments, ∗∗p = 0.0021; ∗∗∗p = 0.00021;
∗∗∗∗p < 0.0001; ns, not significant.
bacteria per chain, but by far the greatest effect was seen in
presence of AliB peptide ligand on strains D39 and 106.66
(Figure 4A). The peptides increased chain length in the
encapsulated strains D39 (serotype 2) and 106.66 (serotype
6B) but not the non-encapsulated strain 110.58 (Figure 4B).
None of the three peptides had any significant effect on chain
length in any of the four mutant strains (Supplementary
Figure S4). By replacing the AliB peptide by the one with
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FIGURE 3 | FITC-dextran exclusion assay to determine the effect of the
peptides on capsule thickness. In CDM, bacteria were grown in the presence
or absence of AmiA, AliA or AliB peptide ligands to OD600nm = 0.2. (A) A
representative fluorescent image shows a visible reduction in capsule size
following incubation with AmiA peptide ligand for both strains D39 and
106.66. (B) Quantification of results with all peptides presented as
mean ± SD of mean area per bacterium in square pixels. Each symbol
represents one image containing between 8 and 150 bacteria. ∗p = 0.0332;
∗∗p = 0.002; ∗∗∗∗p = 0.0001; ns, not significant.
the single amino acid substitution (AIQSEKRRKHN) we show
that the effect on chain length is specific to the AliB peptide
(Figure 4C).
Peptides Affect Biofilm Formation
We found no effect of the peptide ligands on adherence (see
Supplementary Figure S5) but nevertheless we looked for an
effect on biofilm formation. Peptide ligands for AmiA and AliA
significantly increased biofilm formation for all three strains;
D39, 106.66, and 110.58 (Figure 5). AliB peptide ligand caused a
significant increase in biofilm in strains D39 and 110.58, although
to a lesser extent than the other two peptides, but not in strain
106.66 (Figure 5). AmiA peptide increased biofilm production in
FIGURE 4 | Effect of peptides on pneumococcal chain length. In CDM, strain
D39 and its mutants, 106.66 and 110.58 were grown to OD600nm = 0.2 in the
absence and presence of peptide ligands (0.5 mg/mL). (A) Representative
brightfield images showing differences in chain length between controls and
S. pneumoniae treated with AliB peptide ligand. (B) Quantification of results
with all peptides and (C) comparison of effect of AliB ligand with that of a
peptide with a single amino acid substitution (AIQSEKRRKHN) on chain length
of strain D39. Results are presented as mean ± SD of average number of
bacteria per chain. Each symbol represents an image containing between 5
and 78 chains. ∗∗∗p = 0.00021; ∗∗∗∗p = 0.0001; ns, not significant.
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FIGURE 5 | Effect of peptides on biofilm formation. Quantitative analysis of
in vitro biofilm formation of strains D39, 106.66, and 110.58 on Detroit 562
nasopharyngeal epithelial cells in the absence and presence of peptide
ligands (0.5 mg/mL) in CDM after 16 h of static incubation. Results are
expressed as mean CFU/500 µL medium ± SD, ∗p = 0.0332; ∗∗p = 0.0021;
ns, not significant.
FIGURE 6 | Effect of peptides on transformation rate. The rate of
transformation to antibiotic resistance by the uptake of DNA from a resistant
strain was determined for strains D39, 106.66, and 110.58 in the presence of
the appropriate CSP (as indicated on the x-axis) and the absence and
presence of the peptide ligands (0.5 mg/mL). Percentage transformation rates
are the means ± SD of three independent experiments, ∗p = 0.0332;
∗∗p = 0.0021; ns, not significant.
mutant 1AmiA/1AliA/1AliB but not in mutant 1AmiA. AliA
and AliB peptide ligands caused no changes in biofilm formation
in any of the mutants tested (Supplementary Figure S6).
Peptide Ligands Reduced
Transformation Rate
Streptococcus pneumoniae is naturally competent for genetic
transformation and being able to take up DNA in a hostile
environment may confer a survival advantage. The effect of the
peptides on CSP-mediated transformation rate was therefore
tested in the strain D39, its mutants and strains 106.66
and 110.58. All three peptide ligands significantly reduced
the transformation rate in strains D39, 106.66, and 110.58
(Figure 6). No significant effect was observed in the mutants
(Supplementary Figure S7A). It must be noted that the peptide
concentration is high (0.5 mg/mL) relative to the concentration
of CSP (100 ng/mL) and that at such concentrations the AliA
and AliB peptides with single amino acid substitutions and an
irrelevant peptide reduced transformation rate (Supplementary
Figure S7B), although in contrast to AmiA, AliA, and AliB, the
results were not statistically significant.
Peptide Affects Protein Expression
To gain insight into how the peptides caused these phenotype
changes, we also looked at the effect of AmiA, AliA,
and AliB peptide ligands on the pneumococcal proteome.
Proteomic analysis was performed by LC-MS/MS on strain D39
and its mutants 1AmiA, 1AliA, 1AliB, and triple mutant
1AmiA1AliA1AliB in the presence and absence of peptide
ligands. Table 1 shows all proteins significantly upregulated and
downregulated in the wild type following a 15 min exposure
to each of the peptide ligands. Although there was some
overlap of the effect on protein expression between the three
peptides, we noted that only AliB peptide increased expression
of alanine racemase, a protein that catalyses the racemisation of
L-alanine and D-alanine. D-alanine is needed for biosynthesis
of peptidoglycan in the cell wall, essential for AliB peptide-
induced growth. AmiA peptide appeared to switch off expression
of several proteins associated with metabolism such as Vex2,
the ATP-binding protein of an ABC transporter for export of
lipoproteins during cell division, Cof family protein involved
in metabolism and RecN, a protein that repairs DNA during
replication. Two proteins uniquely switched off by AliA were a
replicative DNA helicase and penicillin-binding protein 2X which
is required for building cell wall. These results seem to support the
role of AmiA and AliA proteins in reducing growth. Of interest
was also the CinA protein, which is associated with competence
and was switched on by AmiA and AliA but not AliB.
See Supplementary Table S1 for upregulated and
downregulated proteins in the single and triple mutants in
the presence of the peptides and Supplementary Table S2 for the
complete set of proteins.
DISCUSSION
We propose that there is interspecies communication between
bacteria that live in the human nasopharynx and that detecting
other bacterial species allows S. pneumoniae to adapt to its
environment. Previously, we reported that S. pneumoniae AmiA,
AliA, and AliB lipoproteins of an ABC transporter are able to
bind peptides matching ribosomal proteins of other bacteria
species including common nasopharynx colonisers (Nasher et al.,
2018b). These proteins are encoded by genes of the core
pneumococcal genome (Obert et al., 2006) and so are of relevance
across the pneumococcal population. Here, we looked at what
effects these novel peptide ligands have on the phenotype of the
pneumococcus.
In the presence of AmiA and AliA peptide ligands, growth of
all strains was greatly reduced; by contrast AliB peptide ligand
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TABLE 1 | All proteins significantly upregulated and downregulated in the wild type strain D39 following a 15 min exposure to each of the peptide ligands∗.
Protein ID Name Description AmiA peptide AliA peptide AliB peptide
ABJ53612 Potassium uptake protein, Trk family protein On On
ABJ53738 mraW S-adenosyl-methyltransferase MraW On On On
ABJ54061 Alr Alanine racemase On
ABJ54079 cinA Competence-damage protein, putative On On
ABJ54125 Conserved hypothetical protein On On On
ABJ54281 ABC transporter ATP-binding protein On On
ABJ54300 ispA Geranyltranstransferase Off
ABJ54555 Conserved hypothetical protein Off Off
ABJ54708 scrB Sucrose-6-phosphate hydrolase Off Off Off
ABJ54728 dnaB Replicative DNA helicase Off
ABJ54958 vex2 ABC transporter, ATP-binding protein Vexp2 Off
ABJ54991 Cof family protein Off
ABJ55133 recN DNA repair protein RecN Off
ABJ55135 Oxidoreductase, short chain dehydrogenase/reductase family protein Off Off
ABJ55333 pbpX Penicillin-binding protein 2X Off
ABJ55410 Oxidoreductase, putative Off Off
∗“On” corresponds to detection of the protein in the presence of the peptide specified and zero detection in the absence of the peptide. “Off” corresponds to detection
of the protein in the absence of the peptide specified and zero detection in the presence of the peptide. For complete data values for D39 mutants see Supplementary
Table S1.
slightly boosted growth. Steady but persistent growth may be
an ideal strategy for a coloniser in an environment such as the
nasopharynx where nutrient availability is limited. In contrast
proliferation of the pneumococcus has been suggested to increase
the risk of invasive disease (Albrich et al., 2012).
AmiA and AliA peptides, but not AliB peptide, decreased
capsule thickness. The polysaccharide capsule is the most
important virulence factor of pneumococci, playing a role
in invasive disease (Kelly et al., 1994; Beech et al., 2018).
The capsule prevents phagocytosis mediated by Fcγ receptors,
complement receptors and non-opsonic receptor thus protecting
the pneumococci from the host immune response (Kelly
et al., 1994; Hardy et al., 2001; Hammerschmidt et al., 2005;
Hyams et al., 2010, 2013; Geno et al., 2015). Additionally,
and an increase in capsule size has been observed in systemic
infections (Kim and Weiser, 1998; Kim et al., 1999). However,
capsule is downregulated when pneumococci are in intimate
contact with epithelial cells (Hammerschmidt et al., 2005),
and a transparent phenotype that is associated with improved
colonisation of the nasopharynx has a reduced expression of
capsular polysaccharide (Weiser, 2010). We therefore propose
that when S. pneumoniae comes into contact with AmiA ligand
and AliA ligand, these peptides signal the pneumococci to
downregulate capsule expression which may promote attachment
to epithelial cells, the first step in colonisation. Colonisation
involves biofilm formation and, whilst all three peptides increased
the amount of biofilm, the effect was greatest for AmiA and
AliA peptides. Biofilm formation may provide several advantages
for the pneumococci including a protective environment in
which the bacteria can upregulate factors that are involved in
nutrient uptake from their environment while downregulating
virulence factors involved in inflammation to evade host defence
system (Blanchette-Cain et al., 2013; Qin et al., 2013). Several
previous studies have found that capsule size is inversely
associated with biofilm formation (Hall-Stoodley et al., 2008;
Marks et al., 2012b; Junges et al., 2017). In contrast, proliferating
bacteria are able to transition from colonising to invasive
disease at a higher degree than biofilm forming bacteria
(Trappetti et al., 2011; Marks et al., 2013) suggesting that
AliB peptide might have a higher likelihood than the other
two peptides of being associated with invasion. We found
that peptide ligands for AmiA and AliA particularly increased
biofilm formation, despite not increasing adherence to epithelial
cells in our in vitro model, although others have found a
correlation between adherence and biofilm formation (Konkel
et al., 1997; Marks et al., 2012a; Sulaeman et al., 2012). It is
possible that the peptide ligands enhance biofilm formation
by another mechanism such as enhancing extracellular matrix
formation.
AliB peptide ligand dramatically increased chain formation
and length in the encapsulated strains but not in the non-
encapsulated 110.58. We propose that increasing chain length
may compensate for a thick capsule during colonisation as having
a thicker capsule has also been reported to restrict adherence
to human epithelial cells (Talbot et al., 1996; Adamou et al.,
1998; Ring et al., 1998; Novick et al., 2017). Non-encapsulated
pneumococci have an advantage in adherence and colonisation
(Keller et al., 2016), and may therefore not require increase in
chaining for effective colonisation. If a longer chain allows more
secure attachment as suggested by a recent report (Rodriguez
et al., 2012), the chances of progression to invasive disease may
also be greater.
Our findings indicate that S. pneumoniae transformation
rate can be influenced by other bacterial species. To
our knowledge, there have not been any reports on
the effect of other bacterial species that are common
colonisers of the nasopharynx on the transformation
rate of pneumococcus, although there are several studies
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that highlight that competence and transformation rate of
the pneumococcus is affected by co-colonisation of multiple
serotypes (Donati et al., 2010; Hiller et al., 2010; Croucher
et al., 2011; Muzzi and Donati, 2011; Marks et al., 2012b).
Transformation rate was decreased by all three peptides, despite
the finding that only AmiA and AliA reduced capsule thickness,
but the only competence-associated protein found in the
proteomic studies was CinA which was switched on by AmiA and
AliA but not AliB. Expression of this protein has been previously
shown to be turned on during competence (Martin et al., 1995)
but its role in transformation has not been confirmed (Mortier-
Barrière et al., 1998). Since biofilm formation is generally
associated with increased competence, further studies over a time
course might be warranted to decipher the precise role of the
peptides in competence.
Proteomic data indicated downregulation of some proteins
involved in metabolism or cell division by AmiA peptide (Vex2,
Cof family protein, RecN) and AliA (DnaB, PbpX). These results
are compatible with the phenotypic data, where AmiA and
AliA reduced growth and AliB increased both peptidoglycan
production (Alr) and increased growth. Alr is an alanine
racemase and uses a covalently bound pyridoxal 5′-phosphate
cofactor to catalyse the racemisation of L-alanine and D-alanine.
D-alanine is a necessary component of the peptidoglycan layer in
bacterial cell walls (Lambert and Neuhaus, 1972; Milligan et al.,
2007). In S. mutans, Alr has also been shown to be necessary
for growth and competitiveness (Wei et al., 2016). However,
proteomic data was not clear cut, for example MraW, involved
in cell wall biogenesis was increased by all three peptides,
A limitation in this study was the incubation time of
the pneumococcal strains and the peptide ligands which only
provided a snapshot of the proteome profile. We cannot overlook
the fact that we could have also missed regulation of many
other essential proteins thought to be involved in pneumococcal
pathogenesis. In addition, all our studies investigated the effects
of one peptide ligand for each lipoprotein receptor but we do not
exclude the possibility that other peptides may bind and that their
effects on the pneumococcal phenotypes may be different from
those found in the present study.
We have shown that AmiA, AliA, and AliB peptides, found in
ribosomal proteins of other bacterial species, alter the phenotypes
of S. pneumoniae. We propose that exploiting this knowledge
could offer new targets in the prevention and treatment of
pneumococcal diseases.
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